Imagion Biosystems
Melbourne, Victoria, Australia · Biotechnology, Health Care, Health Diagnostics
Imagion Biosystems is a clinical-stage imaging company pioneering a new category of MRI technology that changes suspicion into certainty. The company has developed and is advancing clinical applications for MagSense®, a first-of-its-class MRI imaging agent that enables clinicians to detect cancer earlier and with greater precision. Advancing molecular MRI, the company uses non-radioactive, bio-saf
Key facts
- Headquarters
- Melbourne, Victoria, Australia
- Employees
- Unknown
- Industries
- Biotechnology, Health Care, Health Diagnostics
- Status
- Private
- Website
- imagionbiosystems.com
- Company page
Recent activity at Imagion Biosystems
Imagion Biosystems funding history
| Date | Round | Amount |
|---|---|---|
| Jun 2026 | Post-IPO Equity | $3.8M |
Leadership
- Carmen Soikowski, Director of Operations
- Ward Detwiler, President
Verified email and direct lines for Imagion Biosystems’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Imagion Biosystems in the news
Companies similar to Imagion Biosystems
- CraniUS™ · Biotechnology, Health Care, Health Diagnostics, Medical, Medical Device, Therapeutics
- Happy Health · Biotechnology, Health Care, Health Diagnostics, Medical, Medical Device
- Colorado Imaging Associates and TRA Medical Imaging · Biotechnology, Health Care, Health Diagnostics, Medical, Medical Device
- TrivarX · Biotechnology, Health Care, Health Diagnostics, Medical, Medical Device
- Proteotype Diagnostics Unipessoal LDA · Biotechnology, Health Care, Health Diagnostics, Medical, Medical Device
About Imagion Biosystems: questions and answers
What does Imagion Biosystems do?
Imagion Biosystems is a clinical-stage imaging company pioneering a new category of MRI technology that changes suspicion into certainty. The company has developed and is advancing clinical applications for MagSense®, a first-of-its-class MRI imaging agent that enables clinicians to detect cancer earlier and with greater precision. Advancing molecular MRI, the company uses non-radioactive, bio-saf
Where is Imagion Biosystems headquartered?
Imagion Biosystems is headquartered in Melbourne, Victoria, Australia.
Has Imagion Biosystems raised funding?
Yes. Fundz has recorded 1 funding event for Imagion Biosystems. The most recent, Post-IPO Equity of $3.8M, was in Jun 2026.
Who leads Imagion Biosystems?
Ward Detwiler is a President at Imagion Biosystems.
What is the latest news on Imagion Biosystems?
On Jun 25, 2026, Imagion Biosystems secures AU$3.75M following FDA clearance for Phase 2 clinical trial of MagSense® imaging in HER2+ breast cancer.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy